Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9979 | 1038 | 33.7 | 62% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
701 | 12232 | RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANTI IDIOTYPIC ANTIBODY | Author keyword | 10 | 33% | 2% | 25 |
2 | ANTI ANTI IDIOTYPIC ANTIBODY | Author keyword | 9 | 83% | 0% | 5 |
3 | INTERNAL IMAGE | Author keyword | 9 | 52% | 1% | 12 |
4 | 105AD7 | Author keyword | 8 | 100% | 0% | 5 |
5 | ANTIIDIOTYPE | Author keyword | 5 | 31% | 1% | 14 |
6 | ANTI IDIOTYPE | Author keyword | 5 | 24% | 2% | 17 |
7 | PEPTIDOMIMICS | Author keyword | 3 | 57% | 0% | 4 |
8 | ANTIIDIOTYPE ANTIBODY | Author keyword | 3 | 50% | 0% | 4 |
9 | 11099 N TORREY PINES RD | Address | 3 | 60% | 0% | 3 |
10 | ANTI IDIOTYPE ANTIBODY | Author keyword | 3 | 24% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTI IDIOTYPIC ANTIBODY | 10 | 33% | 2% | 25 | Search ANTI+IDIOTYPIC+ANTIBODY | Search ANTI+IDIOTYPIC+ANTIBODY |
2 | ANTI ANTI IDIOTYPIC ANTIBODY | 9 | 83% | 0% | 5 | Search ANTI+ANTI+IDIOTYPIC+ANTIBODY | Search ANTI+ANTI+IDIOTYPIC+ANTIBODY |
3 | INTERNAL IMAGE | 9 | 52% | 1% | 12 | Search INTERNAL+IMAGE | Search INTERNAL+IMAGE |
4 | 105AD7 | 8 | 100% | 0% | 5 | Search 105AD7 | Search 105AD7 |
5 | ANTIIDIOTYPE | 5 | 31% | 1% | 14 | Search ANTIIDIOTYPE | Search ANTIIDIOTYPE |
6 | ANTI IDIOTYPE | 5 | 24% | 2% | 17 | Search ANTI+IDIOTYPE | Search ANTI+IDIOTYPE |
7 | PEPTIDOMIMICS | 3 | 57% | 0% | 4 | Search PEPTIDOMIMICS | Search PEPTIDOMIMICS |
8 | ANTIIDIOTYPE ANTIBODY | 3 | 50% | 0% | 4 | Search ANTIIDIOTYPE+ANTIBODY | Search ANTIIDIOTYPE+ANTIBODY |
9 | ANTI IDIOTYPE ANTIBODY | 3 | 24% | 1% | 9 | Search ANTI+IDIOTYPE+ANTIBODY | Search ANTI+IDIOTYPE+ANTIBODY |
10 | RELAY HYPOTHESIS | 2 | 44% | 0% | 4 | Search RELAY+HYPOTHESIS | Search RELAY+HYPOTHESIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERNAL IMAGE | 77 | 58% | 9% | 90 |
2 | MONOCLONAL ANTIIDIOTYPIC ANTIBODY | 28 | 69% | 2% | 24 |
3 | ANTIIDIOTYPIC ANTIBODIES | 14 | 18% | 7% | 71 |
4 | MONOCLONAL ANTIIDIOTYPE ANTIBODY | 13 | 80% | 1% | 8 |
5 | MK2 23 | 12 | 75% | 1% | 9 |
6 | ANTIIDIOTYPIC MONOCLONAL ANTIBODIES | 9 | 50% | 1% | 13 |
7 | IDIOTYPIC ANTIBODIES | 8 | 27% | 3% | 26 |
8 | 105AD7 | 8 | 100% | 0% | 5 |
9 | IDIOTOPES | 8 | 33% | 2% | 19 |
10 | ANTIIDIOTYPIC ANTIBODY | 7 | 21% | 3% | 28 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Anti-idiotype antibody vaccine therapy for cancer | 2002 | 23 | 44 | 75% |
Anti-idiotype vaccine against cancer | 2000 | 34 | 32 | 78% |
ANTIIDIOTYPIC ANTIBODIES - BIOLOGICAL FUNCTION AND STRUCTURAL STUDIES | 1995 | 51 | 35 | 54% |
Monoclonal antibodies for cancer immunotherapy | 2009 | 89 | 82 | 26% |
Antibody-based Vaccines for the treatment of melanoma | 2002 | 8 | 64 | 73% |
Anti-idiotype cancer vaccines: Past and future | 1996 | 19 | 84 | 80% |
IDIOTYPIC VACCINES AND INFECTIOUS-DISEASES | 1988 | 61 | 58 | 69% |
IDIOTYPIC ANTIBODY IMMUNOTHERAPY OF CANCER | 1994 | 22 | 44 | 75% |
IDIOTYPIC NETWORKS AND NATURE OF MOLECULAR MIMICRY - AN OVERVIEW | 1989 | 60 | 97 | 53% |
Internal image concept revisited | 1996 | 28 | 93 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 11099 N TORREY PINES RD | 3 | 60% | 0.3% | 3 |
2 | BARRETT CANC PREVENT TREATMENT | 2 | 43% | 0.3% | 3 |
3 | LUCILLE PARKER MARKEY CANC | 1 | 19% | 0.5% | 5 |
4 | BARRETT CANC | 1 | 13% | 0.7% | 7 |
5 | BIOMED SCI HUMAN ONCOL DIMO | 1 | 23% | 0.3% | 3 |
6 | 36TH SPRUCE ST | 1 | 50% | 0.1% | 1 |
7 | COMPLEMENT REGULAT | 1 | 50% | 0.1% | 1 |
8 | CRC IMMUNOL | 1 | 50% | 0.1% | 1 |
9 | CRC UNIT CLIN ONCOL | 1 | 50% | 0.1% | 1 |
10 | EXPT PATHOL CHIKUSA KU | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000207023 | IG ALLOTYPE//UNITE IMMUNOPHYSIOL MOL//DEXTRAN B512 |
2 | 0.0000146848 | EP CAM//TROP2//EDRECOLOMAB |
3 | 0.0000101781 | IDIOTYPE//IDIOTYPE VACCINATION//CELL THER Y AREA |
4 | 0.0000086802 | POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700 |
5 | 0.0000077621 | NEUGCGM3//N GLYCOLYL GM3//CMP N ACETYLNEURAMINIC ACID HYDROXYLASE |
6 | 0.0000075726 | 5T4//TUMOR IMMUNOL BIOL//5T4 ONCOFETAL ANTIGEN |
7 | 0.0000063174 | HYBROTEC//ASTER YOMENA//ENERGY TRANSFER PROBE |
8 | 0.0000061122 | CANONICAL STRUCTURES//CDR CONFORMATION//ANTIBODY STRUCTURE |
9 | 0.0000060387 | SORBIN//NONCOMPETITIVE IMMUNOASSAY//PHAGE ANTI IMMUNOCOMPLEX ASSAY |
10 | 0.0000057038 | COMPLEMENTARY PEPTIDES//COMPLEMENTARY PEPTIDE//ANTISENSE PEPTIDES |